Cargando…

Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease

Defective solute carrier (SLC) transporters are responsible for neurotransmitter dysregulation, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We provided the role and kinetic parameters of transporters such as ASCTs, Taut, LAT1, CAT1, MCTs, OCTNs, CHT, and CTL1...

Descripción completa

Detalles Bibliográficos
Autores principales: Latif, Sana, Kang, Young-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608738/
https://www.ncbi.nlm.nih.gov/pubmed/36297602
http://dx.doi.org/10.3390/pharmaceutics14102167
_version_ 1784818841154486272
author Latif, Sana
Kang, Young-Sook
author_facet Latif, Sana
Kang, Young-Sook
author_sort Latif, Sana
collection PubMed
description Defective solute carrier (SLC) transporters are responsible for neurotransmitter dysregulation, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We provided the role and kinetic parameters of transporters such as ASCTs, Taut, LAT1, CAT1, MCTs, OCTNs, CHT, and CTL1, which are mainly responsible for the transport of essential nutrients, acidic, and basic drugs in blood–brain barrier (BBB) and motor neuron disease. The affinity for LAT1 was higher in the BBB than in the ALS model cell line, whereas the capacity was higher in the NSC-34 cell lines than in the BBB. Affinity for MCTs was lower in the BBB than in the NSC-34 cell lines. CHT in BBB showed two affinity sites, whereas no expression was observed in ALS cell lines. CTL1 was the main transporter for choline in ALS cell lines. The half maximal inhibitory concentration (IC(50)) analysis of [(3)H]choline uptake indicated that choline is sensitive in TR-BBB cells, whereas amiloride is most sensitive in ALS cell lines. Knowledge of the transport systems in the BBB and motor neurons will help to deliver drugs to the brain and develop the therapeutic strategy for treating CNS and neurological diseases.
format Online
Article
Text
id pubmed-9608738
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96087382022-10-28 Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease Latif, Sana Kang, Young-Sook Pharmaceutics Review Defective solute carrier (SLC) transporters are responsible for neurotransmitter dysregulation, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We provided the role and kinetic parameters of transporters such as ASCTs, Taut, LAT1, CAT1, MCTs, OCTNs, CHT, and CTL1, which are mainly responsible for the transport of essential nutrients, acidic, and basic drugs in blood–brain barrier (BBB) and motor neuron disease. The affinity for LAT1 was higher in the BBB than in the ALS model cell line, whereas the capacity was higher in the NSC-34 cell lines than in the BBB. Affinity for MCTs was lower in the BBB than in the NSC-34 cell lines. CHT in BBB showed two affinity sites, whereas no expression was observed in ALS cell lines. CTL1 was the main transporter for choline in ALS cell lines. The half maximal inhibitory concentration (IC(50)) analysis of [(3)H]choline uptake indicated that choline is sensitive in TR-BBB cells, whereas amiloride is most sensitive in ALS cell lines. Knowledge of the transport systems in the BBB and motor neurons will help to deliver drugs to the brain and develop the therapeutic strategy for treating CNS and neurological diseases. MDPI 2022-10-11 /pmc/articles/PMC9608738/ /pubmed/36297602 http://dx.doi.org/10.3390/pharmaceutics14102167 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Latif, Sana
Kang, Young-Sook
Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title_full Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title_fullStr Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title_full_unstemmed Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title_short Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
title_sort blood–brain barrier solute carrier transporters and motor neuron disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608738/
https://www.ncbi.nlm.nih.gov/pubmed/36297602
http://dx.doi.org/10.3390/pharmaceutics14102167
work_keys_str_mv AT latifsana bloodbrainbarriersolutecarriertransportersandmotorneurondisease
AT kangyoungsook bloodbrainbarriersolutecarriertransportersandmotorneurondisease